New research from Mass General Brigham assesses the utility of over-the-counter continuous glucose monitors (CGMs) in individuals without diabetes and finds limited clinical benefit. While CGMs remain critical for diabetes management, their application in non-diabetic populations may not provide meaningful data to impact health outcomes, raising questions about their widespread consumer adoption beyond prescribed medical contexts.